Diabetes & Hypoglycemia
From Proteopedia
(Difference between revisions)
Line 6: | Line 6: | ||
Articles in Proteopedia concerning [[Diabetes & Hypoglycemia]] include: | Articles in Proteopedia concerning [[Diabetes & Hypoglycemia]] include: | ||
- | *[[Glucose-dependent Insulinotropic Polypeptide Receptor]] | ||
*[[Insulin]] | *[[Insulin]] | ||
+ | *[[Insulin receptor]] | ||
*[[HbA1c test for diabetes]] | *[[HbA1c test for diabetes]] | ||
+ | *[[Glucose-dependent Insulinotropic Polypeptide Receptor]] | ||
*[[User:Mary Ball/Leptin|Leptin]] | *[[User:Mary Ball/Leptin|Leptin]] | ||
*[[Peroxisome Proliferator-Activated Receptors]] | *[[Peroxisome Proliferator-Activated Receptors]] |
Revision as of 12:00, 3 September 2019
Diabetes & Hypoglycemia are metabolic diseases in which a person has either excess blood sugar (Diabetes) or insufficient blood sugar (Hypoglycemia), caused by pancrease β-cell dysfunction, deficiency in insulin secretion or insulin resistance, and/or increased hepatic glucose production.
Articles in Proteopedia concerning Diabetes & Hypoglycemia include:
- Insulin
- Insulin receptor
- HbA1c test for diabetes
- Glucose-dependent Insulinotropic Polypeptide Receptor
- Leptin
- Peroxisome Proliferator-Activated Receptors
- Phosphoinositide 3-Kinases
- YKL-40
To view Diabetes & Hypoglycemia related proteins which are Structure Index entries see:
To view automatically seeded pages concerning Diabetes & Hypoglycemia See:
To View FDA Approved Treatments for Diabetes & Hypoglycemia See: Treatments
To view other Proteopedia pages about diseases & drug targets, See: Pharmaceutical Drug Targets